DMD Digital Health Connections Group Inc (APTOF) - Total Assets
Based on the latest financial reports, DMD Digital Health Connections Group Inc (APTOF) holds total assets worth $10.01 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of DMD Digital Health Connections Group Inc to assess the company's total reinvestment commitment from operating cash flow.
DMD Digital Health Connections Group Inc - Total Assets Trend (2013–2025)
This chart illustrates how DMD Digital Health Connections Group Inc's total assets have evolved over time, based on quarterly financial data. Check APTOF operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
DMD Digital Health Connections Group Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
DMD Digital Health Connections Group Inc's total assets of $10.01 Million consist of 64.4% current assets and 35.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how DMD Digital Health Connections Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is DMD Digital Health Connections Group Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DMD Digital Health Connections Group Inc's current assets represent 64.4% of total assets in 2025, an increase from 18.4% in 2013.
- Cash Position: Cash and equivalents constituted 9.0% of total assets in 2025, up from 0.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 80.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
DMD Digital Health Connections Group Inc Competitors by Total Assets
Key competitors of DMD Digital Health Connections Group Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $8.59 Billion |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
USA | $4.40K |
|
Krystal Biotech Inc
NASDAQ:KRYS
|
USA | $1.40 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
|
USA | $641.76 Million |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
DMD Digital Health Connections Group Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.69 | 2.14 | 1.71 |
| Quick Ratio | 0.69 | 2.14 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.86 Million | $5.07 Million | $7.20 Million |
DMD Digital Health Connections Group Inc - Advanced Valuation Insights
This section examines the relationship between DMD Digital Health Connections Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 67.84 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | $10.01 Million |
| Market Capitalization | $4.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values DMD Digital Health Connections Group Inc's assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: DMD Digital Health Connections Group Inc's assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for DMD Digital Health Connections Group Inc (2013–2025)
The table below shows the annual total assets of DMD Digital Health Connections Group Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $10.01 Million | -1.14% |
| 2024-12-31 | $10.13 Million | -22.03% |
| 2023-12-31 | $12.99 Million | -74.54% |
| 2022-12-31 | $51.03 Million | -38.17% |
| 2021-12-31 | $82.53 Million | +135.07% |
| 2017-12-31 | $35.11 Million | +6.80% |
| 2016-12-31 | $32.87 Million | +23.76% |
| 2015-12-31 | $26.56 Million | +48.24% |
| 2014-12-31 | $17.92 Million | +12.81% |
| 2013-12-31 | $15.88 Million | -- |
About DMD Digital Health Connections Group Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloi… Read more